Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00179855 · ClinicalTrials.gov registry record · Phase 2

Extracorporeal Photopheresis for Acute Graft Versus Host Disease

A Phase 2 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Completed
Registry status
Phase 2
Development phase
10
Enrollment target

NCT00179855: Completed Phase 2 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

NCT00179855 is a Phase 2 study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00179855, a Phase 2 study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

COMPLETED
Registry status
Phase 2
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this research study is to evaluate the safety and feasibility of extracorporeal photopheresis (ECP) in the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in children.

Interventions

  • PROCEDURE Extracorporeal Photopheresis

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2003-07
Est. Completion 2010-08
Phase Phase 2

What the finished NCT00179855 record still lists

NCT00179855 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Extracorporeal Photopheresis is the first listed.

NCT00179855 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00179855 about?

NCT00179855 is a clinical study titled "Extracorporeal Photopheresis for Acute Graft Versus Host Disease". The purpose of this research study is to evaluate the safety and feasibility of extracorporeal photopheresis (ECP) in the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in children.

What is the current status of trial NCT00179855?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2003-07. Estimated completion is 2010-08.

What interventions are being tested in trial NCT00179855?

The interventions under investigation include: Extracorporeal Photopheresis (PROCEDURE).

Who is sponsoring clinical trial NCT00179855?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00179855's enrollment target sits among peer trials

10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00179855, the US trial registry maintained by the National Library of Medicine. NCT00179855 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.